Hints and tips:
Related Special Reports
...JPMorgan Chase chief executive Jamie Dimon yesterday shuffled his leadership team and consolidated some of the bank’s businesses as he grooms potential candidates for an eventual take over from him....
...After visiting Bahrain, where the US Navy’s Fifth Fleet is stationed, the defence secretary will stop aboard the USS Gerald R Ford aircraft carrier, currently in the eastern Mediterranean, and also travel...
...“But it has been a polarising debate, given the potential impact of reforms on R&D budgets and what that means for global innovation.”...
...Instead, it has prioritised internal R&D and smaller acquisitions to add to its drug pipeline....
...“These maps, they are intended to whet the appetite of both government and companies with adequate resources to be able to start down that R&D pathway,” said Terra Rogers, director of superhot rock energy...
...Ireland-based life science companies have tripled R&D spending, as they undertake higher value activities including manufacturing of complex biologic medicines....
...It’s also worth remembering Harvard MBA grads range from disgraced Enron boss, Jeffrey Skilling, to Wall Street superstar, Jamie Dimon....
...So we span the entire pharmaceutical R&D lifecycle.”...
...Last year emerging biopharma companies were responsible for a record 65 per cent of the molecules in the R&D pipeline without a larger company involved, up from less than 50 per cent in 2016 and 34 per cent...
...Energy Source is written and edited by Tom Wilson, Jamie Smyth, Myles McCormick and Amanda Chu, with support from the FT’s global team of reporters....
...The industry is also worried that R&D productivity is falling....
...“Pfizer is very good at selling but historically not renowned as having the R&D engine of a Merck or Lilly....
...From meetings with Sam Altman to a secretive “Project R”, SoftBank boss Masayoshi Son is looking to make a comeback after years and years of bad bets, The Information reports. CEO or CEOs?...
...“The potential new medicines in Horizon’s pipeline strongly complement our own R&D portfolio,” said Bradway....
...I don’t fully understand why they are doing that,” said Wang Lai, BeiGene’s global head of R&D, in an interview in New York....
...This has allowed regions to carry out “complicated market-facing activities” such as attracting foreign direct investment and boosting R&D....
...Analysts said the biotech and its Covid vaccine rival Moderna face a delicate balancing act between investing the proceeds from vaccine sales in R&D and business development to expand their operations while...
...Moderna said the company had evolved from an R&D organisation in 2019 into one that had a commercial product in 2020....
...Taylor, who was mentored by co-founder Roberts, revamped its consumer-focused investments after the disastrous buyout of Toys R Us....
...It has a $40bn backlog of orders to prove demand is still resilient and plans to invest more than €4bn in R&D by 2025 to sustain its pace of innovation....
...To paraphrase a commodity trading Crocodile Dundee talking to the denizens of r/wallstreetbets — “that’s not a short squeeze; this is a short squeeze”: The London Metals Exchange has halted trading in three-month...
...But given it’s 2021, we thought who better to get a reaction from than the great masses of online traders who spend their days on r/wallstreetbets?...
...And the US drugmaker Merck has announced plans to build a £1bn R&D hub called the London Discovery Research Centre, which is also expected to open in 2025....
...of Graham, North Carolina -- Clearinghouses, a love letter -- The vultures behind London’s housing crisis -- In memory of Janos Kornai -- Profit shifting and intangible assets -- Song of the day: R.A.P...
...Greg Glenn, Novavax’s president of R&D, said the mRNA vaccines have some “safety” and issues in terms of adverse side effects, which would make Novavax a particularly attractive option when Covid-19 becomes...
International Edition